|
|
|
|
Lechleiter pay rises in 1st full year as Lilly CEO
Eli Lilly and Co.CEO John Lechleiter received a compensation package valued at $16.4 million for 2009, up 54 percent from 2008, the year he became the drug maker's chief executive, according to an Associated Press calculation of figures disclosed Monday in a...
|
|
|
UDATE 1-NeurogesX sees 'mid-tier' pain-patch price
By Ransdell Pierson NEW YORK, Feb 8 (Reuters) - A new patch for shingles pain that uses the fiery component of chili peppers will likely cost up to $2,500 a year, or a little higher, and be launched in the first half of the year, the chief executive officer of...
|
|
|
Lilly CEO's pay jumps 54 percent in first full year as drug maker's leader
INDIANAPOLIS (AP) Eli Lilly and Co.CEO John Lechleiter received a compensation package valued at $16.4 million for 2009, up 54 percent from 2008, the year he became the drug maker's chief executive, according to an Associated Press calculation of figures...
|
|
|
Lilly CEO's pay jumps 54 percent in first full year as drug maker's leader
INDIANAPOLIS Eli Lilly and Co.CEO John Lechleiter received a compensation package valued at $16.4 million for 2009, up 54 percent from 2008, the year he became the drug maker's chief executive, according to an Associated Press calculation of figures...
|
|
|
Lechleiter pay rises in 1st full year as Lilly CEO
INDIANAPOLIS (AP) -- Eli Lilly and Co.CEO John Lechleiter received a compensation package valued at $16.4 million for 2009, up 54 percent from 2008, the year he became the drug maker's chief executive, according to an Associated Press calculation of figures...
|
|
|
Lilly's Cymbalta significantly reduced chronic low back pain in new study
Keywords: Eli Lilly, Cymbalta, Back pain, Research Related Articles 4 February 2010 1 February 2010 28 January 2010 26 January 2010 Recent Articles 5 February 2010 5 February 2010 5 February 2010 Related Discussion There are no related discussions.
|
|
|
Compound Created At OSU Could Become Important New Antidepressant
Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.A patent has been...
|
|
|
Cymbalta Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS, Feb.3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1)...
|
|
|
Compound created at OSU could become important new antidepressant
Clinical Trials Update Breaking News EUREKALERT Contact: James White 541-737-2173 CORVALLIS, Ore.Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have...
|
|
|
Study shows Cymbalta significantly reduces chronic low back pain
_ Study shows Cymbalta significantly reduces chronic low back pain.
|
|
|
New class of compound could become effective antidepressant with minimal side effects
Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.A patent has been...
|
|
|
Study shows Cymbalta reduces chronic low back pain
In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.The data were presented today at the annual...
|
|
|
Cymbalta Significantly Reduced Chronic Low Back Pain In New Study
Indianapolis, IN /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1) The...
|
|
|
The Columbus Dispatch, Ohio, Joe Blundo column: Feel blue? You must be taking Avatar [The Columbus Dispatch, O
4--I've noticed that the marketing whizzes at pharmaceutical companies favor three-syllable names (Cymbalta, Lipitor, Nasonex) and love the letter 'V' (Viagra, Prevacid, Avodart, Boniva).Maybe that's why Avatar, the blockbuster 3-D movie directed by...
|
|
|
Eli Lilly and Company (LLY): Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS, Feb.3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta(R) (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1) The...
|
|
|
Lilly: Study shows Cymbalta 'signficantly' reduces back pain
INDIANAPOLIS (Feb.3) A pain drug made by Eli Lilly & Co. significantly reduced chronic low back pain compared with placebo, according to a study announced Wednesday by Lilly. The double-blind study, presented at the annual meeting of the American...
|
|
|
LILLY (ELI) & COMPANY - Cymbalta Reduced Chronic Low Back Pain New Study
or Release: Immediately Refer to: Sonja Popp-Stahly, +1 317-655-2993, spopp-stahly@lilly.com Cymbalta, Significantly Reduced Chronic Low Back Pain in New Study INDIANAPOLIS - In a new study, 60 mg of Cymbalta, (duloxetine HCl) taken once daily...
|
|
|
Cymbalta Reduced Chronic Low Back Pain New Study
For Release: Immediately Refer to: Sonja Popp-Stahly, +1 317-655-2993, spopp-stahly@lilly.com Cymbalta Significantly Reduced Chronic Low Back Pain in New Study INDIANAPOLIS - In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily...
|
|
|
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS, Feb.3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1)...
|
|
|
LILLY (ELI) & COMPANY - Cymbalta Reduced Chronic Low Back Pain New Study
For Release: Immediately Refer to: Sonja Popp-Stahly, +1 317-655-2993, spopp-stahly@lilly.com Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study INDIANAPOLIS - In a new study, 60 mg of Cymbalta(R) (duloxetine HCl) taken once daily...
|
|
|
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS A total of 401 patients participated in the 12-week, double-blind, placebo-controlled study, designed to assess the efficacy of duloxetine 60 mg once daily on the reduction of pain severity in patients with chronic low back pain.In the study,...
|
|
|
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS, Feb.3 INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating,...
|
|
|
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
PR Newswire INDIANAPOLIS, Feb.3 INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain...
|
|
|
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS, Feb.3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1)...
|
|
|
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
INDIANAPOLIS, Feb.3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1)...
|
